Description
Indication & Scope
HuaLeSha® Ribavirin Tablets provides broad‑spectrum antiviral therapy for viral pneumonia and bronchitis induced by respiratory syncytial virus; for cutaneous herpes simplex virus infection.
- Mechanism: Inhibits viral RNA synthesis and viral replication through interfering with viral messenger RNA activity.
- Drug class: Synthetic nucleoside antiviral agent.
- Clinical use: Systemic antiviral treatment for respiratory syncytial virus lower‑respiratory‑tract infection and skin herpes virus lesions.
| Generic Name | Ribavirin Tablets |
| Brand Name | HuaLeAn® |
| Ingredient | Ribavirin |
| Dosage Form | Tablets |
| Package | 100mg*24 tablets/box |
| Conditions Treated | Viral pneumonia, viral bronchitis caused by respiratory syncytial virus, cutaneous herpes virus infection |
| Taboos | Contraindicated in pregnancy, lactation, severe hemoglobinopathy, known hypersensitivity to ribavirin or formulation components |
| Place of origin | China |
| Prescription type | Prescription‑only |
| Storage Conditions | Seal and store at room temperature, avoid moisture |
| Manufacturer | Guangdong Huanan Pharmaceutical Group Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | H10950323 |
| Approval Date | Jul 25, 2025 |
| Shelf Life | 24 months |
How to use ?
Recommended Dose: Adult oral dose varies according to disease condition, general routine dose ranges 0.8‑1 g daily divided into multiple administrations.
Time: Taken after meals to reduce gastrointestinal discomfort.
Instructions for use: Swallow whole tablets with water, follow prescribed dosage course; do not arbitrarily extend treatment duration.
Interaction: Concurrent use with zidovudine may reduce therapeutic effect of zidovudine; hematological adverse risk increases when combined with other myelotoxic medicines.
Side effects:
1. Common reactions include gastrointestinal discomfort, dizziness, fatigue.
2. Important severe risk: hemolytic anemia. Hepatic function abnormality may occur occasionally.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
Which virus‑caused respiratory diseases are suitable for Ribavirin Tablets intervention?
It targets pneumonia and bronchitis triggered by respiratory syncytial virus, also treats skin herpes virus infection.
What critical adverse risk should be alerted during medication course of Ribavirin Tablets?
Hemolytic anemia represents key risk indicator; regular blood‑count examination is required in long‑term usage.
Which population must avoid receiving Ribavirin Tablets?
Administration is prohibited for pregnant individuals, lactation status, severe hemoglobinopathy and hypersensitivity cases.
Whether arbitrary prolongation of treatment course is allowed when using Ribavirin Tablets after symptom relief?
Treatment course should strictly comply with medical advice; random prolonged use will raise adverse‑reaction risks.
HuaLeSha® | Ribavirin Tablets | Viral Pneumonia/Bronchitis | DengYueRX
INN: Ribavirin Tablets
Indications: Viral pneumonia and bronchitis
Dosage Form: Tablets
Strength: 100mg/tablet
Original price was: $1.39.$1.18Current price is: $1.18.
